MarketInOut Stock Screener Log In | Sign Up

Neuland Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Neuland Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization256,799 mln
Float7.20 mln
Earnings Date11/03/2026

EPS

392
Exceptional

P / E

49.87
High premium

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.11
Caution advised

1-Year Forecast

24,678
Strong upside

Relative Strength

63 / 100
Outperforming

Business Description

Founded in 1984 and based in Hyderabad, India, Neuland Laboratories is a pharmaceutical company that produces and sells the core chemical ingredients used to make medicines. The company serves customers across India, Europe, the United States, and other global markets. It also offers specialized manufacturing services, including the production of peptides, which are compounds used in a wide range of medical treatments.

Key Fundamentals

EPS392
P/E49.87
ROE29.75
RPS1,849
ROIC25.44
ROA19.51
Interest Cover25.24
EBITDA, mln7,937
EV / EBITDA34.52
EV / EBIT39.39
Revenue, mln23,718
EV / Revenue11.55

Quote Details

Last 19,571
Change 281.35 (1.46%)
Open 19,301
Volume 1,465
Turnover 28,670,928
Average Volume 3,608

Financial Ratios

Pre-Tax Profit Margin28
Current Ratio2.09
Price / Book14.64
Price / Tangible Book17.28
Debt / Equity0.16
Price / Sales11.57
PEG Ratio1.62

Financial Strength

Altman Z-Score18.04
Piotroski F-Score 6 / 9
Beneish M-Score-2.11
Price to Intrinsic Value12.41
Price to Lynch Fair Value2.21
Price to Graham Number7.61
1-Year Target Price24,678
Shiller PE Ratio148

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.65% 72 / 100   
1 Month -8.95% 39 / 100   
2 Months 6.04% 78 / 100   
6 Months 34.09% 89 / 100   
1 Year 20.8% 84 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog